Latest Natus Medical Inc (BABY) Headlines
Mindray Medical International Slips to Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 11, 1:50PM CDT
Mindray has seen a negative trend in earnings estimate revisions in the past 7 days.
Varian Medical Systems Hit 52-Week High - Analyst Blog
Souvik Guha - Zacks Investment Research - Tue Mar 11, 12:38PM CDT
Shares of VAR started escalating following its announcement of several events supporting the increased adoption of the company's technology and the exhibition of a comprehensive line of products in the pipeline.
AngioDynamics Gets 3rd FDA Approval for BioFlo - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 10, 4:30PM CDT
The commercial launch of the catheter, which is expected in the fourth quarter of fiscal year 2014, is likely to boost ANGO's 15% share in the $100 million chronic dialysis catheter market.
Synergetics (SURG) in Focus: Stock Tumbles 11.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Mar 10, 7:59AM CDT
Synergetics' shares fell by over 11% on the day. This continues the recent downtrend for SURG, as the stock is down nearly 6% since Feb 13.
Coverage on Covance Initiated - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 06, 2:20PM CST
On Mar 06, 2014, we initiated coverage on Covance.
Thoratec Warns About HeartMate Controller - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 06, 2:00PM CST
Investors reacted negatively to the news, resulting in a 2.7% fall in THOR shares to $36.22 after the market closed yesterday
Uptrend Call Working As Natus Medical Stock Rises 90.5% (BABY)
Comtex SmarTrend(R) - Thu Mar 06, 10:58AM CST
SmarTrend identified an Uptrend for Natus Medical (NASDAQ:BABY) on October 2nd, 2013 at $14.42. In approximately 5 months, Natus Medical has returned 90.50% as of today's recent price of $27.47.
Mindray Tops on Q4 Earnings - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 04, 2:23PM CST
International revenues grew 23.8% to $208.0 million while revenues from China grew at a slower pace of 8.3% to $160.4 million
In 2013, the European Market for Female Neonatal Diagnostic Devices was Valued at over 410 Million Says Latest Report
M2 - Mon Mar 03, 9:28AM CST
Research and Markets (http://www.researchandmarkets.com/research/8sb44p/european_markets) has announced the addition of the "European Markets for Female and Neonatal Diagnostic Devices (Executive Summary)" report to their offering This report covers devices used for bone densitometry, breast biopsy, breast imaging, OB/GYN ultrasound imaging, infant warmers and incubators. Europe's economic climate will continue to influence the many different sectors examined in this report. Capital equipment sales will be negatively influenced by health care restraints due to economic instability; this effect will be particularly pronounced in the more price sensitive Southern European countries. The well- established and mature OB/GYN ultrasound segment will continue to dominate this market throughout the forecast period. This will be followed by the breast imaging segment, representing just over a quarter of the overall market. This report covers Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland and the United Kingdom. This report pertains to a forecast period of 10 years (2010 - 2020) for the European market. Countries Included: Austria, Belgium, Denmark, Finland, France, Germany, Luxembourg, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, U.K. Scope of the Report - Competitor Analysis - Identified Strategic Opportunities - Market Overview by Segment - Trend Analysis by Segment - Market Drivers & Limiters - Mergers & Acquisitions - Customer Feedback & Market Monitoring Main Segments Included - European Female and Neonatal Diagnostic Device Market - Bone Densitometry Market - Breast Biopsy Device Market - Breast Imaging Market - Obstetrics and Gynecology Ultrasound Market - Infant Warmer and Incubator Market Companies Mentioned: - Agfa - Atom Medical International - B. Braun - BK Medical - Biosound Esaote - Cobams - Cooper Surgical - DMS Group - Ethicon Endo-Surgery - Fisher & Paykel - Fujifilm - GE Healthcare - Ginevri - Heinen-L?wenstein - Hitachi Medical Systems - International Biomedical - Invivo Interventional Instruments - Johnson & Johnson - Konica Minolta - Machnet - M?dipr?ma - NORAS - Natus Medical - Osteometer Meditech - Philips Healthcare - Planmed - Siemens - Toshiba - Toshiba Medical Systems - Ultrasonix - Weyer - Zonare Medical Systems For more information visit http://www.researchandmarkets.com/research/8s...an_markets About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
HeartWare Sees Narrower Loss but Misses Ests - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 03, 8:55AM CST
For full year 2013, HeartWare's loss was also narrower at $52.0 million or $3.24 per share compared with $86.6 million or $6.07 per share in 2012.
Teleflex Beats on Q4 Earnings, Shares Rise - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 28, 12:50PM CST
Following the favorable earnings announcement, shares of Teleflex rose 0.8% till the last closing date.
In 2013, the European Market for Female Neonatal Diagnostic Devices was Valued at Over 410 Million
M2 - Fri Feb 28, 10:39AM CST
Research and Markets (http://www.researchandmarkets.com/research/dj9zpl/european_markets) has announced the addition of the "European Markets for Female and Neonatal Diagnostic Devices" report to their offering. This report covers devices used for bone densitometry, breast biopsy, breast imaging, OB/GYN ultrasound imaging, infant warmers and incubators. Europe's economic climate will continue to influence the many different sectors examined in this report. Capital equipment sales will be negatively influenced by health care restraints due to economic instability; this effect will be particularly pronounced in the more pricesensitive Southern European countries. The well- established and mature OB/GYN ultrasound segment will continue to dominate this market throughout the forecast period. This will be followed by the breast imaging segment, representing just over a quarter of the overall market. This report covers Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland and the United Kingdom. This report pertains to a forecast period of 10 years (2010 - 2020) for the European market. Countries Included: Austria, Belgium, Denmark, Finland, France, Germany, Luxembourg, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, U.K. Main Segments Included - European Female and Neonatal Diagnostic Device Market - Bone Densitometry Market - Breast Biopsy Device Market - Breast Imaging Market - Obstetrics and Gynecology Ultrasound Market - Infant Warmer and Incubator Market Companies Mentioned - Agfa - Anthem - Ardo Medical AG - Argon Medical - Atom Medical International - B. Braun - BK Medical - Biosound Esaote - Brestige - C .R. Bard - CareFusion - Carestream - Cobams - Cooper Surgical - DMS Group - Demetech - Devicor - Draeger Medical - Echosens - Ethicon Endo-Surgery - Fisher & Paykel - Fujifilm - Fujifilm-SonoSite - Fukuda Denshi - GE Healthcare - Ginevri - Heinen-Lowenstein - Hitachi Medical Systems - Hitachi-Aloka - Hologic - IMS Giotto - International Biomedical - Invivo Interventional Instruments - Johnson & Johnson - Konica Minolta - Machnet - Mammotome - Medical ECONET - Mermaid Medical - Metaltronica - Mindray - Mediprema - NORAS - Natus Medical - Osteometer Meditech - Philips Healthcare - Planmed - Planmed OY - Samsung Medison - Siemens Healthcare - Sunlight Medical - Supersonic Imagine - Toshiba - Ultrasonix - Weyer - Zonare Medical Systems For more information visit http://www.researchandmarkets.com/research/dj...an_markets About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Natus Medical Up 79.8% Since SmarTrend Uptrend Call (BABY)
Comtex SmarTrend(R) - Thu Feb 27, 9:33AM CST
SmarTrend identified an Uptrend for Natus Medical (NASDAQ:BABY) on October 2nd, 2013 at $14.42. In approximately 5 months, Natus Medical has returned 79.75% as of today's recent price of $25.92.
Fresenius Medical Care Beats on Q4 Earnings - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 27, 9:20AM CST
For full-year 2013, FMS reported a 6.5% fall in net earnings to $1.1 billion and a 6% drop in net earnings per share to $1.83.
Will Gap (GPS) Miss Earnings this Quarter? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 26, 3:00PM CST
Gap is slated to post its fourth-quarter fiscal 2013 earnings results on Feb 27, 2014.
Q4 Earnings Beat at AmSurg, Poor Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 26, 9:10AM CST
AmSurg Corp.'s fourth-quarter 2013 EPS from continuing operations climbed 22% year over year to 60 cents.
Can Brookdale Senior (BKD) Continue to Surge? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Feb 26, 7:30AM CST
Brookdale Senior Living has seen its Zacks Rank surge over the past four weeks, moving from Sell territory to its current position as a Strong Buy
Balanced View on Omnicell - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 25, 1:50PM CST
On Feb 24, 2014, we issued an updated research report on Omnicell.
DexCom Beats, Sees Narrower Q4 Loss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 25, 8:40AM CST
Owing to narrower reported loss or adjusted earnings in the 2013-fourth quarter, shares of Dexcom rose 3.5% since the announcement of earnings results
Wider Q4 Loss, Poor Outlook at Volcano Corp. - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 25, 8:00AM CST
Volcano Corporation reported adjusted net loss of 29 cents per share in the fourth quarter of 2013, wider than the Zacks Consensus Estimate loss of 24 cents per share.
Mindray Medical International Slips to Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 11, 1:50PM CDT
Mindray has seen a negative trend in earnings estimate revisions in the past 7 days.
Varian Medical Systems Hit 52-Week High - Analyst Blog
Souvik Guha - Zacks Investment Research - Tue Mar 11, 12:38PM CDT
Shares of VAR started escalating following its announcement of several events supporting the increased adoption of the company's technology and the exhibition of a comprehensive line of products in the pipeline.
AngioDynamics Gets 3rd FDA Approval for BioFlo - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 10, 4:30PM CDT
The commercial launch of the catheter, which is expected in the fourth quarter of fiscal year 2014, is likely to boost ANGO's 15% share in the $100 million chronic dialysis catheter market.
Synergetics (SURG) in Focus: Stock Tumbles 11.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Mar 10, 7:59AM CDT
Synergetics' shares fell by over 11% on the day. This continues the recent downtrend for SURG, as the stock is down nearly 6% since Feb 13.
Coverage on Covance Initiated - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 06, 2:20PM CST
On Mar 06, 2014, we initiated coverage on Covance.
Thoratec Warns About HeartMate Controller - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 06, 2:00PM CST
Investors reacted negatively to the news, resulting in a 2.7% fall in THOR shares to $36.22 after the market closed yesterday
Uptrend Call Working As Natus Medical Stock Rises 90.5% (BABY)
Comtex SmarTrend(R) - Thu Mar 06, 10:58AM CST
SmarTrend identified an Uptrend for Natus Medical (NASDAQ:BABY) on October 2nd, 2013 at $14.42. In approximately 5 months, Natus Medical has returned 90.50% as of today's recent price of $27.47.
Mindray Tops on Q4 Earnings - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 04, 2:23PM CST
International revenues grew 23.8% to $208.0 million while revenues from China grew at a slower pace of 8.3% to $160.4 million
In 2013, the European Market for Female Neonatal Diagnostic Devices was Valued at over 410 Million Says Latest Report
M2 - Mon Mar 03, 9:28AM CST
Research and Markets (http://www.researchandmarkets.com/research/8sb44p/european_markets) has announced the addition of the "European Markets for Female and Neonatal Diagnostic Devices (Executive Summary)" report to their offering This report covers devices used for bone densitometry, breast biopsy, breast imaging, OB/GYN ultrasound imaging, infant warmers and incubators. Europe's economic climate will continue to influence the many different sectors examined in this report. Capital equipment sales will be negatively influenced by health care restraints due to economic instability; this effect will be particularly pronounced in the more price sensitive Southern European countries. The well- established and mature OB/GYN ultrasound segment will continue to dominate this market throughout the forecast period. This will be followed by the breast imaging segment, representing just over a quarter of the overall market. This report covers Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland and the United Kingdom. This report pertains to a forecast period of 10 years (2010 - 2020) for the European market. Countries Included: Austria, Belgium, Denmark, Finland, France, Germany, Luxembourg, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, U.K. Scope of the Report - Competitor Analysis - Identified Strategic Opportunities - Market Overview by Segment - Trend Analysis by Segment - Market Drivers & Limiters - Mergers & Acquisitions - Customer Feedback & Market Monitoring Main Segments Included - European Female and Neonatal Diagnostic Device Market - Bone Densitometry Market - Breast Biopsy Device Market - Breast Imaging Market - Obstetrics and Gynecology Ultrasound Market - Infant Warmer and Incubator Market Companies Mentioned: - Agfa - Atom Medical International - B. Braun - BK Medical - Biosound Esaote - Cobams - Cooper Surgical - DMS Group - Ethicon Endo-Surgery - Fisher & Paykel - Fujifilm - GE Healthcare - Ginevri - Heinen-L?wenstein - Hitachi Medical Systems - International Biomedical - Invivo Interventional Instruments - Johnson & Johnson - Konica Minolta - Machnet - M?dipr?ma - NORAS - Natus Medical - Osteometer Meditech - Philips Healthcare - Planmed - Siemens - Toshiba - Toshiba Medical Systems - Ultrasonix - Weyer - Zonare Medical Systems For more information visit http://www.researchandmarkets.com/research/8s...an_markets About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
HeartWare Sees Narrower Loss but Misses Ests - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 03, 8:55AM CST
For full year 2013, HeartWare's loss was also narrower at $52.0 million or $3.24 per share compared with $86.6 million or $6.07 per share in 2012.
Teleflex Beats on Q4 Earnings, Shares Rise - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 28, 12:50PM CST
Following the favorable earnings announcement, shares of Teleflex rose 0.8% till the last closing date.
In 2013, the European Market for Female Neonatal Diagnostic Devices was Valued at Over 410 Million
M2 - Fri Feb 28, 10:39AM CST
Research and Markets (http://www.researchandmarkets.com/research/dj9zpl/european_markets) has announced the addition of the "European Markets for Female and Neonatal Diagnostic Devices" report to their offering. This report covers devices used for bone densitometry, breast biopsy, breast imaging, OB/GYN ultrasound imaging, infant warmers and incubators. Europe's economic climate will continue to influence the many different sectors examined in this report. Capital equipment sales will be negatively influenced by health care restraints due to economic instability; this effect will be particularly pronounced in the more pricesensitive Southern European countries. The well- established and mature OB/GYN ultrasound segment will continue to dominate this market throughout the forecast period. This will be followed by the breast imaging segment, representing just over a quarter of the overall market. This report covers Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland and the United Kingdom. This report pertains to a forecast period of 10 years (2010 - 2020) for the European market. Countries Included: Austria, Belgium, Denmark, Finland, France, Germany, Luxembourg, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, U.K. Main Segments Included - European Female and Neonatal Diagnostic Device Market - Bone Densitometry Market - Breast Biopsy Device Market - Breast Imaging Market - Obstetrics and Gynecology Ultrasound Market - Infant Warmer and Incubator Market Companies Mentioned - Agfa - Anthem - Ardo Medical AG - Argon Medical - Atom Medical International - B. Braun - BK Medical - Biosound Esaote - Brestige - C .R. Bard - CareFusion - Carestream - Cobams - Cooper Surgical - DMS Group - Demetech - Devicor - Draeger Medical - Echosens - Ethicon Endo-Surgery - Fisher & Paykel - Fujifilm - Fujifilm-SonoSite - Fukuda Denshi - GE Healthcare - Ginevri - Heinen-Lowenstein - Hitachi Medical Systems - Hitachi-Aloka - Hologic - IMS Giotto - International Biomedical - Invivo Interventional Instruments - Johnson & Johnson - Konica Minolta - Machnet - Mammotome - Medical ECONET - Mermaid Medical - Metaltronica - Mindray - Mediprema - NORAS - Natus Medical - Osteometer Meditech - Philips Healthcare - Planmed - Planmed OY - Samsung Medison - Siemens Healthcare - Sunlight Medical - Supersonic Imagine - Toshiba - Ultrasonix - Weyer - Zonare Medical Systems For more information visit http://www.researchandmarkets.com/research/dj...an_markets About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Natus Medical Up 79.8% Since SmarTrend Uptrend Call (BABY)
Comtex SmarTrend(R) - Thu Feb 27, 9:33AM CST
SmarTrend identified an Uptrend for Natus Medical (NASDAQ:BABY) on October 2nd, 2013 at $14.42. In approximately 5 months, Natus Medical has returned 79.75% as of today's recent price of $25.92.
Fresenius Medical Care Beats on Q4 Earnings - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 27, 9:20AM CST
For full-year 2013, FMS reported a 6.5% fall in net earnings to $1.1 billion and a 6% drop in net earnings per share to $1.83.
Will Gap (GPS) Miss Earnings this Quarter? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 26, 3:00PM CST
Gap is slated to post its fourth-quarter fiscal 2013 earnings results on Feb 27, 2014.
Q4 Earnings Beat at AmSurg, Poor Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 26, 9:10AM CST
AmSurg Corp.'s fourth-quarter 2013 EPS from continuing operations climbed 22% year over year to 60 cents.
Can Brookdale Senior (BKD) Continue to Surge? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Feb 26, 7:30AM CST
Brookdale Senior Living has seen its Zacks Rank surge over the past four weeks, moving from Sell territory to its current position as a Strong Buy
Balanced View on Omnicell - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 25, 1:50PM CST
On Feb 24, 2014, we issued an updated research report on Omnicell.
DexCom Beats, Sees Narrower Q4 Loss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 25, 8:40AM CST
Owing to narrower reported loss or adjusted earnings in the 2013-fourth quarter, shares of Dexcom rose 3.5% since the announcement of earnings results
Wider Q4 Loss, Poor Outlook at Volcano Corp. - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 25, 8:00AM CST
Volcano Corporation reported adjusted net loss of 29 cents per share in the fourth quarter of 2013, wider than the Zacks Consensus Estimate loss of 24 cents per share.
